Valuation: Ovation Science Inc.

Market Cap 769K 541K 485K 447K 406K 50.74M 790K 5.36M 2.13M 27.19M 2.03M 1.99M 85.95M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 980K 690K 618K 570K 518K 64.66M 1.01M 6.82M 2.72M 34.64M 2.59M 2.53M 110M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.96%
Yield 2024 *
-
Yield 2025 -
1 day-33.33%
Current month-33.33%
1 month-33.33%
3 months-33.33%
6 months-33.33%
Current year-50.00%
1 month 0.02
Extreme 0.02
0.02
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.09
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 29/10/2023
Chief Executive Officer 77 03/10/2017
Director of Finance/CFO 60 19/10/2026
Director TitleAgeSince
Director/Board Member 77 03/10/2017
Director/Board Member 63 03/10/2017
Director/Board Member 86 01/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/04/25 Buy

Director

100,000 0.2642%
31/01/25 Other

Director

0 0.0000%
31/01/25 Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
-33.33%0.00%-50.00%-66.67% 541K
+0.20%+4.07%+15.92%+11.39% 391B
+0.21%+0.02%+24.71%+7.28% 263B
+0.12%-0.65%-4.77%+11.18% 142B
+0.15%+2.58%+25.00%+30.04% 77.97B
-1.05%+6.03%+7.44%-8.34% 67.97B
+0.62%-2.24%+26.38% - 53.2B
+1.27%+1.92%-16.99%-19.12% 49.88B
+0.24%+7.63%+26.55%-1.15% 41.1B
+0.31%+5.26%+18.76%+39.28% 22.29B
Average -3.12%+3.05%+7.30%+0.43% 111B
Weighted average by Cap. +0.19%+3.22%+14.96%+9.10%

Financials

2024 2025
Net sales 113K 79.7K 71.47K 65.87K 59.82K 7.47M 116K 789K 314K 4M 299K 293K 12.66M 67.89K 47.79K 42.86K 39.5K 35.87K 4.48M 69.78K 473K 188K 2.4M 179K 176K 7.59M
Net income -456K -321K -288K -265K -241K -30.11M -469K -3.18M -1.27M -16.13M -1.21M -1.18M -51M -631K -444K -399K -367K -334K -41.66M -649K -4.4M -1.75M -22.32M -1.67M -1.63M -70.57M
Net Debt 265K 187K 167K 154K 140K 17.5M 273K 1.85M 736K 9.38M 701K 686K 29.64M 211K 148K 133K 123K 111K 13.91M 217K 1.47M 585K 7.45M 557K 545K 23.56M
Projected Income Statement - Annual - Ovation Science Inc.
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. OVAT Stock